Orforglipron
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
Eli Lilly · Phase 1 · Completed · Enrollment 50
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Cohort 1: Oral Drug Dosing With or Without Orforglipron Co-Administration | n/r | n/r | n/r | n/r |
| Cohort 2: Oral Drug Dosing With or Without Orforglipron Co-Administration | n/r | n/r | n/r | n/r |
Not shown
- Cohort 1: Oral Drug Dosing With or Without Orforglipron Co-Administration: endpoint not reported
- Cohort 2: Oral Drug Dosing With or Without Orforglipron Co-Administration: endpoint not reported